DK1146897T3 - Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle - Google Patents

Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Info

Publication number
DK1146897T3
DK1146897T3 DK00906234T DK00906234T DK1146897T3 DK 1146897 T3 DK1146897 T3 DK 1146897T3 DK 00906234 T DK00906234 T DK 00906234T DK 00906234 T DK00906234 T DK 00906234T DK 1146897 T3 DK1146897 T3 DK 1146897T3
Authority
DK
Denmark
Prior art keywords
mia
cartilage
activity factor
inhibitory activity
bone repair
Prior art date
Application number
DK00906234T
Other languages
English (en)
Inventor
Carola Dony
Gabriele Proetzel
Ulrike Leser-Reiff
Original Assignee
Carola Dony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carola Dony filed Critical Carola Dony
Application granted granted Critical
Publication of DK1146897T3 publication Critical patent/DK1146897T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00906234T 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle DK1146897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99101315A EP1025871A1 (en) 1999-01-28 1999-01-28 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
PCT/EP2000/000623 WO2000044401A1 (en) 1999-01-28 2000-01-27 Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair

Publications (1)

Publication Number Publication Date
DK1146897T3 true DK1146897T3 (da) 2003-02-03

Family

ID=8237403

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906234T DK1146897T3 (da) 1999-01-28 2000-01-27 Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle

Country Status (11)

Country Link
US (1) US6890897B1 (da)
EP (2) EP1025871A1 (da)
JP (2) JP4800483B2 (da)
AT (1) ATE224731T1 (da)
AU (1) AU765929B2 (da)
CA (1) CA2361238C (da)
DE (1) DE60000501T2 (da)
DK (1) DK1146897T3 (da)
ES (1) ES2180514T3 (da)
PT (1) PT1146897E (da)
WO (1) WO2000044401A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035128A1 (fr) * 2001-10-25 2003-05-01 Japan Science And Technology Agency Substance biologique composite
WO2003066083A1 (fr) * 2002-02-04 2003-08-14 Sumitomo Pharmaceuticals Company, Limited Preparations pour le traitement de fracture osseuse de deperdition osseuse ou d'augmentation la densite osseuse
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US8114841B2 (en) 2004-10-14 2012-02-14 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix
CA2641860C (en) 2006-02-09 2015-07-14 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
ES2664229T3 (es) 2006-06-30 2018-04-18 Biomimetic Therapeutics, Llc Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US7671014B2 (en) * 2006-08-14 2010-03-02 Warsaw Orthopedic, Inc. Flowable carrier matrix and methods for delivering to a patient
ES2708851T3 (es) * 2006-10-06 2019-04-11 Bionet Pharma Gmbh Un implante del núcleo pulposo espinal
EP3181157B1 (en) 2006-11-03 2019-08-14 BioMimetic Therapeutics, LLC Compositions and methods for arthrodetic procedures
CN105854074B (zh) 2008-02-07 2019-10-15 生物模拟治疗有限责任公司 用于牵引成骨术的组合物和方法
US9616153B2 (en) 2008-04-17 2017-04-11 Warsaw Orthopedic, Inc. Rigid bone graft substitute
AU2009291828C1 (en) 2008-09-09 2016-03-17 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
US8492335B2 (en) 2010-02-22 2013-07-23 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
CN102869679B (zh) 2010-04-27 2015-11-25 Scil技术股份有限公司 稳定的水性mia/cd-rap制剂
WO2018129470A1 (en) * 2017-01-09 2018-07-12 The Board Of Trustees Of The Leland Stanford Junior University Reversing deficient hedgehog signaling restores deficient skeletal regeneration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919929A (en) * 1984-02-01 1990-04-24 Stolle Research & Development Corporation Mammal immunization
CA2071912C (en) * 1990-11-30 2002-10-15 Hanne Bentz Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
ATE185152T1 (de) * 1993-07-20 1999-10-15 Roche Diagnostics Gmbh Melanom-inhibierendes protein
TW369414B (en) * 1994-09-30 1999-09-11 Yamanouchi Pharma Co Ltd Bone formation transplant
US6027742A (en) * 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
JPH10194987A (ja) * 1997-01-14 1998-07-28 Youtai Iwamoto 骨・軟骨形成用組成物
US7041641B2 (en) * 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
DE59810255D1 (de) * 1997-10-16 2004-01-08 Scil Technology Holding Gmbh Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
EP1025871A1 (en) 2000-08-09
PT1146897E (pt) 2003-02-28
CA2361238C (en) 2010-08-10
DE60000501T2 (de) 2003-02-13
JP2011084574A (ja) 2011-04-28
AU2799000A (en) 2000-08-18
US6890897B1 (en) 2005-05-10
DE60000501D1 (de) 2002-10-31
EP1146897B1 (en) 2002-09-25
JP4800483B2 (ja) 2011-10-26
ATE224731T1 (de) 2002-10-15
CA2361238A1 (en) 2000-08-03
JP2002537229A (ja) 2002-11-05
WO2000044401A1 (en) 2000-08-03
EP1146897A1 (en) 2001-10-24
AU765929B2 (en) 2003-10-02
ES2180514T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
DK1146897T3 (da) Anvendelse af en melanominhiberende aktivitetsfaktor (MIA) til reparation af brusk og knogle
NO962304D0 (no) BMP-12, BMP-13 og sene-induserende sammensetninger derav
DE60006356D1 (de) Hochmineralisierte osteogene schwammzusammensetzungen und ihre verwendung
DE69528058D1 (de) Bmp-9 zusammensetzungen
DK0796855T3 (da) Hæmmere af knogleresorption og vitronectin-receptorantagonister
ES2113857T3 (es) Composiciones osteoinductoras.
DE59711081D1 (de) Marknagelsystem zur frakturheilung bzw. knochenverlängerung
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
ATE371650T1 (de) Cycloalkyl-derivate als inhibitoren der knochenresorption und vitronectinrezeptor- antagonisten
DE60213800D1 (de) Nagel und Schraube für chirurgisches Fixationssystem
DK1690874T3 (da) BMP-12, BMP-13 og sene-inducerende sammensætninger deraf
NO20005928L (no) Bicykliske pyrimidiner og bicykliske 3,4-dihydropyrimidiner som inhibitorer av cellulær proliferasjon
NO973400D0 (no) Nye aminoderivater som inhibitorer av benresorpsjon og vitronektinreseptorantagonister
DE69427345T2 (de) Verwendung von bisphosphonaten in der knochenchirurgie
DE59711220D1 (de) Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender aktivität
DE60221804D1 (de) Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
ATE277902T1 (de) Amidinoderivate und ihre verwendung als thrombininhibitoren
DE68913991D1 (de) Implantat zur verwendung in der knochenchirurgie.
DE60019389D1 (de) Chirurgischer Schwenkhaltering zur Verwendung in der Augenchirurgie
DE69708629D1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
ATE299703T1 (de) Mmp-hemmer bei bindegewebserweichung
FR2811229B1 (fr) Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse
DK0601152T3 (da) Osteosyntesehjælpemiddel til fiksering af knogler.
DK1274426T3 (da) Anvendelse af thioamidoxazolidinoner til behandling af knogleresorption og osteoporose
ATE400292T1 (de) Verwendung von leptin bei unfruchtbarkeit